Psychedelic Sacraments and the New Psychotherapy – Synergistic Press, Spring 2017
Changing Our Minds is an experiential tour through a social, spiritual and scientific revolution that is redefining our culture’s often confusing relationship with psychoactive substances. Veteran journalist Don Lattin chronicles the inspiring stories of pioneering neuroscientists, psychotherapists, spiritual leaders and ordinary people seeking to lead healthier lives by combining psychedelic drugs, psychotherapy, and the wise use of ancient plant medicines.
The Botanical Mind: Art, Mysticism and The Cosmic Tree was originally conceived as a trans-generational group exhibition, but has been postponed. In the meantime, we have launched this complimentary online programme of new artist commissions, podcasts, films, texts, images and audio, expanding on and enriching the ideas and issues informing the show over at www.botanicalmind.online.
Drawing on indigenous traditions from the Amazon rainforest; alternative perspectives on Western scientific rationalism; and new thinking around plant intelligence, philosophy and cultural theory, The Botanical Mind Online investigates the significance of the plant kingdom to human life, consciousness and spirituality across cultures and through time. It positions the plant as both a universal symbol found in almost every civilisation and religion across the globe, and the most fundamental but misunderstood form of life on our planet
Entangled Life: How Fungi Make Our Worlds, Change Our Minds & Shape Our Futures is a 2020 nonfiction book on mycology by English biologist Merlin Sheldrake – brother of our talented musician Cosmo Sheldrake! His first book, it was published by Random House on 12 May 2020
Meditation and psychedelics have played key roles in humankind’s search for self-transcendence and personal change. However, neither their possible synergistic effects, nor related state and trait predictors have been experimentally studied. To elucidate these issues, we administered double-blind the model psychedelic drug psilocybin (315 μg/kg PO) or placebo to meditators (n = 39) during a 5-day mindfulness group retreat.
Neuroscientist Franz Vollenweider shares his work using state-of the-art neuroimaging tools to explore the brain activity patterns underlying the psychological dimensions of psychedelic-induced altered states of consciousness (ASC).